Published in:
Open Access
01-12-2019 | Antibiotic | Letter
Attainment of therapeutic vancomycin level within the first 24 h: Authors' response
Authors:
João Pedro Baptista, Jason A. Roberts, Eduardo Sousa, Ricardo Freitas, Nuno Devesa, Jorge Pimentel
Published in:
Critical Care
|
Issue 1/2019
Login to get access
Excerpt
In sepsis, time is life. However,
time is not the only variable of the complex equation of antibiotic therapy; the dose of antibiotic administered needs to be
adequate. Subtherapeutic antibiotic concentrations potentially lead to decreased microbial killing, treatment failure, and emergence of resistance and/or increased mortality. Early therapeutic drug monitoring and timely dose optimization, ideally during the first 24 h, minimize the likelihood of subtherapeutic antibiotic concentrations and ineffective antibiotic therapy. Vancomycin remains a first-line option for the treatment of methicillin-resistant
Staphylococcus aureus and other resistant Gram-positive bacteria. Of note, vancomycin is one of the antibiotics with the highest likelihood of under dosing [
1]. Continuous infusion (CI), after adequate loading dose (LD), seems to have pharmacological advantages in the critically ill and enables more consistent achievement of therapeutic exposures. …